Unity Biotechnology, Inc. Share Price

NASDAQ: UBX

$0.20

-0.10

(-33.44%)

as on July 9, 2025 at 1:29 am IST

$₹

The stock has been delisted from the stock exchange on 8 Jul 2025

Unity Biotechnology, Inc. Stock Performance

as on July 9, 2025 at 1:29 am IST

$0.2
Day's Price Range
$0.2
$0.2
52 Week's High
$0.2
52-Week Price Range
$3.1
$0.2
1450.00%
Upside

Unity Biotechnology, Inc. share price movements today

Previous Close: $0.30
Open: $0.20
Volume: 6.6K
Day's Low - High: $0.2 - $0.2
52 Week Low - High: $0.2 - $3.1

Unity Biotechnology, Inc. Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Unity Biotechnology, Inc. Stock Fundamentals & Key Indicators

Check Unity Biotechnology, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

0.00%

Unity Biotechnology, Inc. stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Unity Biotechnology, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Unity Biotechnology, Inc.	BUY	$-	NA	NA	0.00%

Analyst Recommendation on Unity Biotechnology, Inc. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Unity Biotechnology, Inc.. Average target price of $3.25

Unity Biotechnology, Inc. Share Price Target

Get share price movements and forecasts by analysts on Unity Biotechnology, Inc..

What analysts predicted

93.85%UPSIDE

Target Price

$3.25

Current Price

$0.2

Analyzed by

8 Analysts

Target

$3.25

Unity Biotechnology, Inc. target price $3.25, a slight upside of 93.85% compared to current price of $0.2. According to 8 analysts rating.

Unity Biotechnology, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	0	-	-	-	-	1	-	-	-	-
Gross Profit	0	0	0	0	-	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-13	-12	-12	-15	-1	-5	-5	-6	-8	-7
Net Profit Margin	5830.08%	0.00%	0.00%	0.00%	0.00%	-304.42%	0.00%	0.00%	0.00%	0.00%

Unity Biotechnology, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	1	-	-	-	4	0	-	-
Gross Profit	0	-35	-2	-2	-3	1	-1	-19	-
Operating Income	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-30	-44	-76	-74	-91	-60	-57	-39	-25
Net Profit Margin	0.00%	-3231.26%	0.00%	0.00%	0.00%	-1255.00%	-24469.07%	0.00%	0.00%

Global Institutional Holdings in Unity Biotechnology, Inc.

Funds	Holdings
ARCH VENTURE CORP	5.84%
Vanguard Group Inc	3.91%
Alyeska Investment Group, L.P.	1.7%
Financial Harvest, LLC	1.19%
Geode Capital Management, LLC	0.97%

See all

About Unity Biotechnology, Inc.

UNITY Biotechnology, Inc. is a biotechnology company engaged in researching and developing therapeutics to slow, halt or reverse diseases of aging. The Company is focused on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. It is targeting specific biological mechanisms implicated in diseases of aging. Its core therapeutic approach targets cellular senescence, and it is advancing senolytic programs primarily in ophthalmologic disorders. It has other programs based on other biologies of aging to include an agonistic antibody to the Tie2 receptor and a Tie2/VEGF bispecific to treat vascular eye disease. UBX1325 is its advanced drug candidate for age-related diseases of the eye, including diabetic macular edema. UBX1325 is a potent small molecule inhibitor of BCL-xL. UBX2089, an a-Klotho hormone drug candidate, is being researched for multiple neurology indications.

Organisation	Unity Biotechnology, Inc.
E-voting on shares	Click here to vote

FAQs

What is Unity Biotechnology, Inc. share price today?

Unity Biotechnology, Inc. share price today is $0.2 as on July 9, 2025 at 1:29 am IST at the close of the market. Unity Biotechnology, Inc. share today touched a day high of $0.2 and a low of $0.2.

What is the 52 week high and 52 week low for Unity Biotechnology, Inc. share?

Unity Biotechnology, Inc. share touched a 52 week high of $3.1 on January 23, 2025 and a 52 week low of $0.2 on July 8, 2025. Unity Biotechnology, Inc. stock price today i.e. July 9, 2025 at 1:29 am IST is closed at $0.2,which is 93.55% down from its 52 week high and 0.00% up from its 52 week low.

How to invest in Unity Biotechnology, Inc. Stock (UBX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Unity Biotechnology, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Unity Biotechnology, Inc. Shares that will get you 7.5000 shares as per Unity Biotechnology, Inc. share price of $0.2 per share as on July 9, 2025 at 1:29 am IST.

What is the minimum amount required to buy Unity Biotechnology, Inc. Stock (UBX) from India?

Indian investors can start investing in Unity Biotechnology, Inc. (UBX) shares with as little as ₹88.27 or $1 (as of September 14, 2025 at 6:08 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Unity Biotechnology, Inc. stock (as per the Rupee-Dollar exchange rate as on September 14, 2025 at 6:08 am IST). Based on Unity Biotechnology, Inc. share’s latest price of $0.2 as on July 9, 2025 at 1:29 am IST, you will get 50.0000 shares of Unity Biotechnology, Inc.. Learn more about fractional shares .